|
PF-08634404 Clinical Trials
10 actively recruiting trials across 7 locations
▲ +1 trial since June 2026
Also known as: SSGJ-707
Pipeline
Phase 2: 2Phase 3: 2Phase 1/2: 4Phase 2/3: 2
Top Sponsors
- Pfizer10
Indications
- Cancer10
- Lung Cancer5
- Non Small Cell Lung Cancer3
- Carcinoma, Non-Small-Cell Lung (NSCLC)2
- Small Cell Lung Cancer (SCLC)2
Fayetteville, Arkansas3 trials
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Highlands Oncology Group, PA
Phase 1/2
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Highlands Oncology Group
Phase 2/3
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Highlands Oncology Group, PA
Phase 1/2
Los Angeles, California2 trials
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Los Angeles Hematology Oncology Medical Group
Phase 2/3
Bullhead City, Arizona1 trial
Chandler, Arizona1 trial
Phoenix, Arizona1 trial
Duarte, California1 trial
Hinsdale, Illinois1 trial
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Hope and Healing Clinical Research
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.